Fibrosis: ILB®, Low Molecular Weight Dextran Sulfate (LMW-DS) Shows Anti-Fibrotic Effects in Pre-Clinical Trial (Q112628320)
Jump to navigation
Jump to search
Article published in Scientific European on 8 January 2021
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fibrosis: ILB®, Low Molecular Weight Dextran Sulfate (LMW-DS) Shows Anti-Fibrotic Effects in Pre-Clinical Trial |
Article published in Scientific European on 8 January 2021 |
Statements
Fibrosis: ILB®, Low Molecular Weight Dextran Sulfate (LMW-DS) Shows Anti-Fibrotic Effects in Pre-Clinical Trial (English)
0 references
8 January 2021
0 references